We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$5.36B
AUM Growth
+$854M
Cap. Flow
+$792M
Cap. Flow %
14.77%
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168

Top Sells

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.1M
2
ZBH icon
Zimmer Biomet
ZBH
+$56.1M
3
NVDA icon
NVIDIA
NVDA
+$55.8M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$54.7M
5
EBAY icon
eBay
EBAY
+$40.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.89%
2 Technology 25.02%
3 Communication Services 8.75%
4 Financials 5.58%
5 Industrials 4.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHIL
201
DELISTED
Benson Hill, Inc.
BHIL
$5.94M 0.11%
+17,143
New +$6.01M
BOLT icon
202
Bolt Biotherapeutics
BOLT
$7.67M
$5.9M 0.11%
19,084
+378
+2% +$153K
PRVA icon
203
Privia Health
PRVA
$2.98B
$5.89M 0.11%
+132,750
New +$4.9M
BARK icon
204
BARK
BARK
$81.8M
$5.85M 0.11%
+26,388
New +$5.7M
AGGR
205
DELISTED
Agile Growth Corp
AGGR
$5.81M 0.11%
+599,999
New +$5.85M
TNGX icon
206
Tango Therapeutics
TNGX
$4.43B
$5.73M 0.11%
503,397
DRVN icon
207
Driven Brands
DRVN
$2.35B
$5.62M 0.1%
181,710
KURA icon
208
Kura Oncology
KURA
$800M
$5.58M 0.1%
+267,683
New +$6.65M
TBPH icon
209
Theravance Biopharma
TBPH
$874M
$5.44M 0.1%
+374,912
New +$7.04M
ABNB icon
210
Airbnb
ABNB
$89.9B
$5.44M 0.1%
35,519
-21,790
-38% -$3.42M
EHC icon
211
Encompass Health
EHC
$11B
$5.42M 0.1%
87,279
-106,548
-55% -$7.1M
BLSA
212
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.4M 0.1%
512,616
HOLX
213
DELISTED
Hologic
HOLX
$5.3M 0.1%
79,449
-103,509
-57% -$6.92M
TIXT
214
DELISTED
TELUS International
TIXT
$5.12M 0.1%
164,425
+4,425
+3% +$133K
REVHU
215
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$5.04M 0.09%
500,000
BPMC
216
DELISTED
Blueprint Medicines
BPMC
$5.02M 0.09%
57,056
-31,850
-36% -$2.92M
RXDX
217
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$4.98M 0.09%
202,682
-7,642
-4% -$170K
IDYA icon
218
IDEAYA Biosciences
IDYA
$3.42B
$4.97M 0.09%
236,695
-53,254
-18% -$1.09M
HNST icon
219
The Honest Company
HNST
$402M
$4.96M 0.09%
+306,501
New +$5.13M
S icon
220
SentinelOne
S
$6.53B
$4.96M 0.09%
+116,668
New +$4.96M
VTRS icon
221
Viatris
VTRS
$20.4B
$4.95M 0.09%
346,500
-1,384,945
-80% -$20M
ULCC icon
222
Frontier Group Holdings
ULCC
$1.55B
$4.95M 0.09%
+290,450
New +$5.73M
LEAP
223
DELISTED
Ribbit LEAP, Ltd.
LEAP
$4.95M 0.09%
462,722
-800
-0.2% -$8.64K
CVII
224
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$4.87M 0.09%
+500,000
New +$4.9M
AAQC
225
DELISTED
Accelerate Acquisition Corp
AAQC
$4.84M 0.09%
+500,000
New +$4.85M

Similar funds

Woodline Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.

  • Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
  • Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
  • Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
  • Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
  • Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
  • Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
  • Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.

Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.